Forster M, Brana I, Lopez Pousa A, Doger B, et al. Eftilagimod alpha (soluble LAG-3 protein) combined with pembrolizumab as second-line therapy for patients with metastatic head and neck squamous cell carcinoma. Clin Cancer Res 2024 Jul 12. doi: 10.1158/1078-0432.CCR-24-0473.
PMID: 38995265